Cargando…
Implementation of immunochemical faecal occult blood test in general practice: a study protocol using a cluster-randomised stepped-wedge design
BACKGROUND: Colorectal cancer is a common malignancy and a leading cause of cancer-related death. Half of patients with colorectal cancer initially present with non-specific or vague symptoms. In the need for a safe low-cost test, the immunochemical faecal occult blood test (iFOBT) may be part of th...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940713/ https://www.ncbi.nlm.nih.gov/pubmed/27400657 http://dx.doi.org/10.1186/s12885-016-2477-9 |
_version_ | 1782442186266116096 |
---|---|
author | Juul, Jakob Søgaard Bro, Flemming Hornung, Nete Andersen, Berit Sanne Laurberg, Søren Olesen, Frede Vedsted, Peter |
author_facet | Juul, Jakob Søgaard Bro, Flemming Hornung, Nete Andersen, Berit Sanne Laurberg, Søren Olesen, Frede Vedsted, Peter |
author_sort | Juul, Jakob Søgaard |
collection | PubMed |
description | BACKGROUND: Colorectal cancer is a common malignancy and a leading cause of cancer-related death. Half of patients with colorectal cancer initially present with non-specific or vague symptoms. In the need for a safe low-cost test, the immunochemical faecal occult blood test (iFOBT) may be part of the evaluation of such patients in primary care. Currently, Danish general practitioners have limited access to this test. The aim of this article is to describe a study that will assess the uptake and clinical use of iFOBT in general practice. Furthermore, it will investigate the diagnostic value and the clinical implications of using iFOBT in general practice on patients presenting with non-alarm symptoms of colorectal cancer. METHODS/DESIGN: The study uses a cluster-randomised stepped-wedge design and is conducted in the Central Denmark Region among 836 GPs in 381 general practices. The municipalities of the Region and their appertaining general practitioners will be included sequentially in the study during the first 7 months of the 1-year study period. The following intervention has been developed for the study: a mandatory intervention providing all general practitioners with a starting package of 10 iFOBTs, a clinical instruction on iFOBT use in general practice and online information material from the date of inclusion, and an optional intervention consisting of a continuous medical education on colorectal cancer diagnostics and use of iFOBT. DISCUSSION: This study is among the first and largest trials to investigate the diagnostic use and the clinical value of iFOBT on patients presenting with non-alarm symptoms of colorectal cancer. The findings will be of national and international importance for the future planning of colorectal cancer diagnostics, particularly for ‘low-risk-but-not-no-risk’ patients with non-alarm symptoms of colorectal cancer. TRIAL REGISTRATION: A Trial of the Implementation of iFOBT in General Practice NCT02308384. Date of registration: 26 November 2014 |
format | Online Article Text |
id | pubmed-4940713 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-49407132016-07-13 Implementation of immunochemical faecal occult blood test in general practice: a study protocol using a cluster-randomised stepped-wedge design Juul, Jakob Søgaard Bro, Flemming Hornung, Nete Andersen, Berit Sanne Laurberg, Søren Olesen, Frede Vedsted, Peter BMC Cancer Study Protocol BACKGROUND: Colorectal cancer is a common malignancy and a leading cause of cancer-related death. Half of patients with colorectal cancer initially present with non-specific or vague symptoms. In the need for a safe low-cost test, the immunochemical faecal occult blood test (iFOBT) may be part of the evaluation of such patients in primary care. Currently, Danish general practitioners have limited access to this test. The aim of this article is to describe a study that will assess the uptake and clinical use of iFOBT in general practice. Furthermore, it will investigate the diagnostic value and the clinical implications of using iFOBT in general practice on patients presenting with non-alarm symptoms of colorectal cancer. METHODS/DESIGN: The study uses a cluster-randomised stepped-wedge design and is conducted in the Central Denmark Region among 836 GPs in 381 general practices. The municipalities of the Region and their appertaining general practitioners will be included sequentially in the study during the first 7 months of the 1-year study period. The following intervention has been developed for the study: a mandatory intervention providing all general practitioners with a starting package of 10 iFOBTs, a clinical instruction on iFOBT use in general practice and online information material from the date of inclusion, and an optional intervention consisting of a continuous medical education on colorectal cancer diagnostics and use of iFOBT. DISCUSSION: This study is among the first and largest trials to investigate the diagnostic use and the clinical value of iFOBT on patients presenting with non-alarm symptoms of colorectal cancer. The findings will be of national and international importance for the future planning of colorectal cancer diagnostics, particularly for ‘low-risk-but-not-no-risk’ patients with non-alarm symptoms of colorectal cancer. TRIAL REGISTRATION: A Trial of the Implementation of iFOBT in General Practice NCT02308384. Date of registration: 26 November 2014 BioMed Central 2016-07-11 /pmc/articles/PMC4940713/ /pubmed/27400657 http://dx.doi.org/10.1186/s12885-016-2477-9 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Study Protocol Juul, Jakob Søgaard Bro, Flemming Hornung, Nete Andersen, Berit Sanne Laurberg, Søren Olesen, Frede Vedsted, Peter Implementation of immunochemical faecal occult blood test in general practice: a study protocol using a cluster-randomised stepped-wedge design |
title | Implementation of immunochemical faecal occult blood test in general practice: a study protocol using a cluster-randomised stepped-wedge design |
title_full | Implementation of immunochemical faecal occult blood test in general practice: a study protocol using a cluster-randomised stepped-wedge design |
title_fullStr | Implementation of immunochemical faecal occult blood test in general practice: a study protocol using a cluster-randomised stepped-wedge design |
title_full_unstemmed | Implementation of immunochemical faecal occult blood test in general practice: a study protocol using a cluster-randomised stepped-wedge design |
title_short | Implementation of immunochemical faecal occult blood test in general practice: a study protocol using a cluster-randomised stepped-wedge design |
title_sort | implementation of immunochemical faecal occult blood test in general practice: a study protocol using a cluster-randomised stepped-wedge design |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940713/ https://www.ncbi.nlm.nih.gov/pubmed/27400657 http://dx.doi.org/10.1186/s12885-016-2477-9 |
work_keys_str_mv | AT juuljakobsøgaard implementationofimmunochemicalfaecaloccultbloodtestingeneralpracticeastudyprotocolusingaclusterrandomisedsteppedwedgedesign AT broflemming implementationofimmunochemicalfaecaloccultbloodtestingeneralpracticeastudyprotocolusingaclusterrandomisedsteppedwedgedesign AT hornungnete implementationofimmunochemicalfaecaloccultbloodtestingeneralpracticeastudyprotocolusingaclusterrandomisedsteppedwedgedesign AT andersenberitsanne implementationofimmunochemicalfaecaloccultbloodtestingeneralpracticeastudyprotocolusingaclusterrandomisedsteppedwedgedesign AT laurbergsøren implementationofimmunochemicalfaecaloccultbloodtestingeneralpracticeastudyprotocolusingaclusterrandomisedsteppedwedgedesign AT olesenfrede implementationofimmunochemicalfaecaloccultbloodtestingeneralpracticeastudyprotocolusingaclusterrandomisedsteppedwedgedesign AT vedstedpeter implementationofimmunochemicalfaecaloccultbloodtestingeneralpracticeastudyprotocolusingaclusterrandomisedsteppedwedgedesign |